Interim Phase 3 analysis of the Oxford / AstraZeneca Covid-19 vaccine candidate showed a 70.4 percent efficacy in preventing the disease, Oxford University announced on Monday. At two different dosing regimens, the vaccine, AZD1222, was 90% and 62% effective. In the most effective dosing regimen, AZD1222 was administered as a …
Read More »
Written by Kaunain Sheriff M | New Delhi | Updated: November 20, 2020 9:52:14 am “Further evaluation of the efficacy of this vaccine is warranted in all age groups and individuals with comorbidities,” the researchers said. The Oxford-AstraZeneca Covid-19 candidate vaccine has triggered a robust immune response in older adults …
Read More »
By: Desk Explained | New Delhi | Updated: September 16, 2020 7:37:30 am The AstraZeneca-Oxford vaccine was among the leading global candidates. AstraZeneca, which is creating a vaccine for the new coronavirus in partnership with the University of Oxford, halted its global vaccine trial on September 6 after a participant …
Read More »
By: Desk Explained | Pune | Updated: September 3, 2020 10:29:01 am A volunteer is injected with a test vaccine as part of a vaccine trial at a London clinic. (AP Photo, Kirsty Wigglesworth, file) Coronavirus Vaccine Tracker (COVID-19): The new coronavirus vaccine you are developing Oxford University and AstraZeneca …
Read More »